Autopsy report · NCT02374957
Cilostazol After Lower Extremity Arterial Revascularization Trial
Cause of deathStaffing, sites or logistics
“Original PI left institution”
Life of this trial
- Ran for about 2 years 4 months before it stopped.
- 20 participants enrolled.
- Results were posted on the registry 1 year 5 months after it ended.
Vital statistics
- Status
- Terminated
- Phase
- Phase 4
- Sponsor
- Wake Forest University Health Sciences
- Sponsor type
- University, hospital or other
- Conditions
- Peripheral Arterial Disease; Claudication (Finding)
- Interventions
- Cilostazol
- Participants
- 20
- Sites
- 1
- Countries
- United States
Trials that died the same way
- Effects of Metformin and Fish Oil on Treatment With Clozapine
“PI left institution” - Oscillatory Versus Non-Oscillatory Nasal Continuous Airway Pressure Neonatal Respiratory Support
“PI has left Institution” - Use of Levemir® Improves Metabolic and Clinical Status in Cystic Fibrosis-related Diabetes (CFRD)
“PI left the institution”
Look deeper
- The official registry record (the source of truth)
- Record history: every change the sponsor made
- Open it in the database
Everything here comes from the current ClinicalTrials.gov record. The timeline uses the record’s dates; dates marked planned are the sponsor’s plans. The cause of death is an automatic, unverified label. This is research information, not medical advice.